Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00793481 · ClinicalTrials.gov registry record
Vascular Reactivity in Metabolic Syndrome and Diabetic Patients Using Diffuse Optical Spectroscopy
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 50
- Enrollment target
NCT00793481 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 50 participants.
The verdict
NCT00793481 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Metabolic Syndrome is a highly prevalent condition that is comprised of several major clustering factors that increase the risk for developing cardiovascular disease. Diffuse Optical Spectroscopy is a non-invasively measure can show changes in the microvasculature of human. Diffuse Optical Spectroscopy measures the optical absorption and scattering properties of near-infrared light in tissues such as muscle in order to quantify the absolute concentration of oxygenated and deoxygenated hemoglobin, water, and lipids. It provides quantitative and functional information on the microvasculature related to tissue perfusion, metabolic changes, and indicators of tissue damage.
Interventions
- DEVICE Diffuse Optical Spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-11 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00793481
The ClinicalTrials.gov registry entry for NCT00793481 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diffuse Optical Spectroscopy is the first listed.
NCT00793481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00793481 about?
NCT00793481 is a clinical study titled "Vascular Reactivity in Metabolic Syndrome and Diabetic Patients Using Diffuse Optical Spectroscopy". Metabolic Syndrome is a highly prevalent condition that is comprised of several major clustering factors that increase the risk for developing cardiovascular disease. Diffuse Optical Spectroscopy is a non-invasively measure can show changes in the microvasculature of human. Diffuse Optical Spectrosc...
What is the current status of trial NCT00793481?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2008-11. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00793481?
The interventions under investigation include: Diffuse Optical Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00793481?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.